About
Arif Khan, MD, is affiliated with the Northwest Clinical Research Center in Bellevue, Washington, and has contributed to 12 articles published between 2001 and 2026. The work focuses on psychiatric conditions including major depressive disorder, anxiety disorders, bipolar disorder, panic disorder, and somatoform disorders, with particular attention to pharmacologic treatments such as vilazodone, bupropion-dextromethorphan, aripiprazole, venlafaxine, ziprasidone, and risperidone. Research topics also encompass clinical trial design, placebo response, and metabolic effects related to psychotropic medications. Frequent collaborators include Donald S. Robinson, Michael E. Thase, Seth Cohen, Shirin Khan, and Adam Ruth.
